Recent advances in the analyses of the characteristics of tumors on FDG uptake

Nuclear Medicine and Biology

Volumn 25, Issue 7, 1998, Pages 589-592

  Waki, Atsuo ^a   Fujibayashi, Yasuhisa ^a   Yokoyama, Akira ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Fluorodeoxyglucose; Glucose metabolism; Tumor biology

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER CELL; CANCER CYTODIAGNOSIS; CELL PROLIFERATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SHORT SURVEY;

ANIMALS; BIOLOGICAL TRANSPORT; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0031666317     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00047-X     Document Type: Short Survey

References (60)

1. Baldwin S.A. Regulation of the glucose transporter GLUT1 in mammalian cells. Biochem. Soc. Trans. 22:1994;814-817.
2. Birnbaum M.J. Transformation of rat fibroblasts by FSV rapidly increase glucose transporter gene transcription. Science. 235:1987;1495-1498.
3. Board M. Maximum activities of key enzymes of glucolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem. J. 265:1990;503-509.
4. Board M. High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose. Cancer Res. 55:1995;3278-3285.
5. Brown R.S. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-d-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J. Nucl. Med. 34:1993;75-82.
6. Brown R.S. Overexpression of GLUT-1 glucose transporter in human breast cancer An immno-histochemical study . Cancer. 72:1993;2979-2985.
7. Burk D. On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas. J. Natl. Cancer Inst. 38:1967;839-863.
8. Clavo A.C. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J. Nucl. Med. 36:1995;1625-1632.
9. Conti P.S. PET and [18F]-FDG in oncology A clinical update . Nucl. Med. Biol. 23:1996;717-735.
10. Eigenbrodt E. New perspectives on carbohydrate metabolism in tumor cells. Beitner R. Regulation of Carbohydrate Metabolism. vol. II:1986;141-180 CRC Press, Boca Raton, FL.
11. Flier J.S. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 235:1987;1492-1495.
12. Fujibayashi Y. Transient increase in glycolytic metabolism in cultured tumor cells immediately after exposure to ionizing radiation From gene expression to deoxyglucose uptake . Radiat. Res. 147:1997;729-734.
13. Gallagher B.M. Metabolic trapping as a principle of radiopharmaceutical design Some factors responsible for the biodistribution of F-18-2-deoxy-2-fluoro-d-glucose . J. Nucl. Med. 19:1978;1154-1161.
14. Gonzalez M.F. Inhibition of glycolysis by amino acids in ascites tumor cells. Specificity and mechanism. J. Biol. Chem. 268:1993;7809-7817.
15. Haberkorn U. Glucose uptake, perfusion, and cell proliferation in head and neck tumors Relation of positron emission tomography to flow cytometry . J. Nucl. Med. 32:1991;1548-1555.
16. Haberkorn U. Fluorodeoxyglucose uptake in vitro Aspects of method and effects of treatment with gemcitabine . J Nucl. Med. 35:1994;1842-1850.
17. Haberkorn U. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl. Med. Biol. 21:1994;827-834.
18. Hatanaka M. Transport of sugars in tumor cell membrane. Biochim. Biophys. Acta. 355:1974;77-104.
19. Higashi K. In vitro assessment of 2-fluoro-2-deoxy-d-glucose, l-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J. Nucl. Med. 34:1993;773-779.
20. Higashi K. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J. Nucl. Med. 34:1993;414-419.
21. Higashi T. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J. Nucl. Med. 38:1997;1337-1344.
22. Hubner K.F. The accuracy of positron emission tomography (PET) and 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) in characterizing lung masses using SUVs and Patlak information. Paans A.H.J., Prium J., Franssen E.J.F., Vaalburg W. Metabolic Imaging of Cancer. 1996;66-68 PET-Centrum Academisch Ziekenhuis Groningen.
23. James D.E. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature. 333:1988;183-185.
24. Kahn B.B. Regulation of glucose-transporter gene expression in vitro and in vivo. Diabetes Care. 13:1990;548-564.
25. Kester M.V. Changes in glycolytic enzyme levels and isoenzyme expression in human lymphocytes during balst transformation. Arch. Biochem. Biophys. 183:1978;700-708.
26. Klip A. Hexose transport in L6 muscle cells. Kinetic properties and the number of [3H]cytochalasin B binding sites. Biochim. Biophys. Acta. 687:1982;265-280.
27. Knox W.E. Hexokinase, differentiation and growth rates of transplanted rat tumors. Cancer Res. 30:1970;2240-2244.
28. Kozma L. The ras signaling pathway mimics insulin action on glucose transporter translocation. Proc. Natl. Acad. Sci. USA. 90:1993;4460-4464.
29. Kubota R. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 33:1992;1972-1980.
30. Kubota K. FDG accumulation in tumor tissue [editorial; comment]. J. Nucl. Med. 34:1993;419-421.
31. Kubota R. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo A microautoradiographic study . J. Nucl. Med. 35:1994;104-112.
32. Kubota R. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J. Nucl. Med. 35:1994;104-112.
33. Kubota R. Methionine uptake by tumor tissue A microautoradiographic comparison with FDG . J. Nucl. Med. 36:1995;484-492.
34. Leskinen-Kallio S. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma A PET study . J. Nucl. Med. 32:1991;1211-1218.
35. Mathupala S.P. Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J. Biol. Chem. 270:1995;16918-16925.
36. Mellanen P. Expression of glucose transporters in head-and-neck tumors. Int. J. Cancer. 56:1994;622-629.
37. Mercado C.L. Enhanced glucose transport in response to inhibition of respiration in Clone 9 cells. Am. J. Physiol. 257:1989;C19-C28.
38. Merrall N.W. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal. 5:1993;667-675.
39. Minn H. Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer. 61:1988;1776-1781.
40. Minn H. Determination of 2-fluoro-2-deoxy-d-glucose uptake and ATP level for evaluating drug effects in neoplastic cells. Res. Exp. Med. Berl. 191:1991;27-35.
41. Minn H. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and l-methionine in squamous-cell carcinoma of the head and neck. J. Nucl. Med. 36:1995;252-258.
42. Minn H. Influence of hypoxia on tracer accumulation in squamous-cell carcinoma In vitro evaluation for PET imaging . Nucl. Med. Biol. 23:1996;941-946.
43. Murakami T. Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J. Biol. Chem. 267:1992;9300-9306.
44. Nishioka T. Distribution of the glucose transporters in human brain tumors. Cancer Res. 52:1992;3972-3979.
45. Okada J. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma A comparison with proliferative activity . J. Nucl. Med. 33:1992;325-329.
46. Pasternak C.A. Regulation of glucose uptake by stressed cells. J. Cell Physiol. 149:1991;324-331.
47. Rempel A. Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim. Biophys. Acta. 1219:1994;660-668.
48. Rempel A. Glucose catabolism in cancer cells Amplification of the gene encoding type II hexokinase . Cancer Res. 56:1996;2468-2471.
49. Schek N. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Cancer Res. 48:1988;6354-6359.
50. Shetty M. Enhancement of glucose transport in response to inhibition of oxidative metabolism Pre- and posttranslational mechanisms . Am. J. Physiol. 262:1992;C527-C532.
51. Slosman D.O. Fluorodeoxyglucose cell incorporation as an index of cell proliferation Evaluation of accuracy in cell culture . Eur. J. Nucl. Med. 20:1993;1084-1088.
52. Slosman D.O. Lack of correlation between tritiated deoxyglucose, thallium-201 and technetium-99m-MIBI cell incorporation under various cell stresses. J. Nucl. Med. 35:1994;120-126.
53. Sokoloff L. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization Theory, procedure, and normal values in the conscious and anesthetized albino rat . J. Neurochem. 28:1977;897-916.
54. Vaupel P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors A review . Cancer Res. 49:1989;6449-6465.
55. Wahl R.L. Targeting glucose transporters for tumor imaging "Sweet" idea, "sour" result [editorial; comment] . J. Nucl. Med. 37:1996;1038-1041.
56. Waki A. Effects of antitumor agents of H-3-2-deoxyglucose uptake in tumor cells and their relationship with the main targets of the antitumor agents. Ann. Nucl. Med. 11:1997;183-188.
57. Waki A. Reassessment of FDG uptake in tumor cells High FDG uptake as a reflection of oxygen-independent glycolysis dominant energy production . Nucl. Med. Biol. 24:1997;665-670.
58. Warburg O. On the origin of cancer cells. Science. 123:1956;309-314.
59. Warren A.P. Stress induces an increased hexose uptake in cultured cells. J. Cell Physiol. 128:1986;383-388.
60. Yamamoto T. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170:1990;223-230.